Search

Search Constraints

You searched for: Author/Creator Latimer, Maya

Search Results

1. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. Issue 6 (June 2022)

2. Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Issue 12 (22nd November 2021)

3. Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID‐19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell. Issue 1 (24th January 2023)

4. Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID‐19 pandemic. Issue 6 (15th May 2020)

6. COVID‐19 vaccination in haematology patients: an Australian and New Zealand consensus position statement. Issue 5 (27th May 2021)

7. Diagnosis and treatment of MYH9-RD in an Australasian cohort with thrombocytopenia. (17th November 2018)

8. Diagnosis, management and follow up of peripheral T‐cell lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance. Issue 10 (20th October 2022)

9. Diffuse large B‐cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Issue 9 (21st July 2022)